Not Out Of The Dark Yet: UK’s NICE Turns Down Clinuvel’s Phototoxicity Drug Scenesse

Sun rays
Patients with hypersensitivity to light will need to wait a little longer for a NICE decision

More from Health Technology Assessment

More from Market Access